NWPF

News ArchivesRead News

The Colorful History of Vibratory Therapy for PD: Does It Have Place in Today's Treatment Armamentarium?

Thursday August 27, 2009

About.com - C.G. Goetz is one of the world's premier Parkinson's disease specialists and he has an avid interest in the history of medicine-particularly the history of the scientific study of the movement disorders.

His recent investigations into the treatment of movement disorders at Paris' famed Salpêtrière Hospital has turned up some interesting facts about J.-M. Charcot's work with PD patients.

Charcot was one of the most famous neurologists of the 19th century. He trained or influenced many of the best and brightest of the physicians of that century including Sigmund Freud.

Charcot claims to have noticed that PD patients slept better and felt better after a bumpy train ride or carriage transport and then surmised that the vibrations caused by these rides had a therapeutic effect of some kind. Charcot developed a vibration chair for patients with PD where patients sat in the chair each day for 30 minutes and then felt better.

Another 19th century famous movement disorders pioneer (and colleague of Charcot), Gilles de la Tourette (after whom Tourette's syndrome is named) developed a helmet that vibrated the head on the premise that the brain responded directly to the pulsations.

Goetz notes that various forms fo vibratory therapy are in use in various branches of medicine today and he seems to leave open the possibility that vibratory medicine for selected PD symptoms might be worth looking at again today.

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement